Changing Paradigms of Feline Idiopathic Cystitis

Veterinary Clinics of North America - Small Animal Practice

Volumn 39, Issue 1, 2009, Pages 15-40

  Kruger, John M ^a   Osborne, Carl A ^b   Lulich, Jody P ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Feline; Idiopathic cystitis; Lower urinary tract disease; Pathogenesis

Indexed keywords

ANTIINFECTIVE AGENT; GLYCOSAMINOGLYCAN;

BACTERIAL INFECTION; CAT DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL FEATURE; CRYSTALLURIA; CYSTITIS; DIVERTICULOSIS; DYSURIA; FELINE FOAMY VIRUS; HEMATURIA; HERPES VIRUS; HUMAN; IDIOPATHIC CYSTITIS; LOWER URINARY TRACT SYMPTOM; MAST CELL; NEUROENDOCRINE DISEASE; NEUROGENIC INFLAMMATION; NONHUMAN; PATHOGENESIS; POLLAKISURIA; RECURRENT DISEASE; REVIEW; SURVIVAL; UROTHELIUM; VESIVIRUS; VIRUS INFECTION;

ANIMAL HUSBANDRY; ANIMALS; BEHAVIOR, ANIMAL; CAT DISEASES; CATS; CYSTITIS; FEMALE; MALE; PEDIGREE; RISK FACTORS; SEX FACTORS;

FELIDAE;

EID: 56449103483     PISSN: 01955616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cvsm.2008.09.008     Document Type: Review

References (171)

1. Buffington C.A.T., Chew D.J., Kendall M.S., et al. Clinical evaluation of cats with nonobstructive urinary tract diseases. J Am Vet Med Assoc 210 (1997) 46-50
2. Gerber B., Boretti F.S., Kley S., et al. Evaluation of clinical signs and causes of lower urinary tract disease in European cats. J Small Anim Pract 46 (2005) 571-577
3. Kruger J.M., Osborne C.A., Goyal S.M., et al. Clinical evaluation of cats with lower urinary tract disease. J Am Vet Med Assoc 199 (1991) 211-216
4. Lekcharoensuk C., Osborne C.A., and Lulich J.P. Epidemiologic study of risk factors for lower urinary tract diseases in cats. J Am Vet Med Assoc 218 (2001) 1429-1435
5. Kalkstein T.S., Kruger J.M., and Osborne C.A. Feline idiopathic lower urinary tract disease: part I. Clinical manifestations. Compend Contin Educ Prac Vet 21 (1999) 15-26
6. Kruger J.M., and Osborne C.A. Managing feline idiopathic cystitis. In: Bonagura J., and Kirk R.W. (Eds). Current veterinary therapy XIV (2009), WB Saunders Co., Philadelphia 944-950
7. In: Gove P.B. (Ed). Webster's third new international dictionary (1993), Merriam-Webster Inc., Springfield (MA) 1635
8. Osborne C.A., Kruger J.M., Lulich J.P., et al. Feline urologic syndrome, feline lower urinary tract disease, feline interstitial cystitis: what's in a name?. J Am Vet Med Assoc 214 (1999) 1470-1480
9. Westropp J.L., and Buffington C.A.T. In vivo models of interstitial cystitis. J Urol 167 (2002) 694-702
10. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49 Suppl 5A (1997) 14-40
11. Mayer R. Interstitial cystitis pathogenesis and treatment. Curr Opin Infect Dis 20 (2007) 77-82
12. Barsanti J.A., Finco D.R., Scotts E.B., et al. Feline urologic syndrome: further investigations into therapy. J Am Anim Hosp Assoc 18 (1982) 387-390
13. Kruger J.M., and Osborne C.A. Recurrent, nonobstructive, idiopathic feline lower urinary tract disease: an illustrative case report. J Am Anim Hosp Assoc 31 (1995) 312-316
14. Kruger J.M., Conway T.S., Kaneene J.B., et al. Randomized controlled trial of the efficacy of short-term amitriptyline administration for treatment of acute, nonobstructive idiopathic lower urinary tract disease in cats. J Am Vet Med Assoc 222 (2003) 749-758
15. Osborne C.A., Kruger J.M., Lulich J.P., et al. Prednisolone therapy of idiopathic feline lower urinary tract disease: a double-blind clinical study. Vet Clin North Am Small Anim Pract 26 3 (1996) 563-570
16. Gunn-Moore D.A., and Shenoy C.M. Oral glucosamine and the management of feline idiopathic cystitis. J Feline Med Surg 6 (2004) 219-225
17. Markwell P.J., Buffington C.A.T., Chew D.J., et al. Clinical evaluation of commercially available urinary acidification diets in the management of idiopathic cystitis in cats. J Am Vet Med Assoc 214 (1999) 361-365
18. Osborne C.A., Kruger J.M., Lulich J.P., et al. Feline lower urinary tract disease: the Minnesota experience. San Antonio (TX). Proceedings of the 15th Annual ACVIM Forum (1997) 338-339
19. Chew D.J., Buffington C.A.T., Kendall M.S., et al. Amitriptyline treatment for severe recurrent idiopathic cystitis in cats. J Am Vet Med Assoc 213 (1998) 1282-1286
20. Westropp J.L., Buffington C.A.T., and Chew D. Feline lower urinary tract diseases. In: Ettinger S.J., and Feldman E.C. (Eds). Textbook of veterinary internal medicine. 6th edition (2005), Elsevier Saunders, St. Louis (MO) 1828-1850
21. Engle G.C. A clinical report on 250 cases of feline urological syndrome. Feline Pract 7 (1977) 24-27
22. Meier F.W. Urethroadenocystitis in the male cat. J Am Vet Med Assoc 151 (1967) 1059-1071
23. Osbaldiston G.W., and Taussig R.A. Clinical report on 46 cases of feline urological syndrome. Vet Med Small Anim Clin 65 (1970) 461-468
24. Mosier J.E. Treatment of canine cystitis. J Am Anim Hosp Assoc 2 (1966) 11-14
25. Swenson C.L., Kruger J.M., Gibbons-Burgener S.N., et al. Accurate detection of bacteriuria in cats. J Vet Intern Med 18 (2004) 441
26. Swenson C.L., Boisvert A.G., Kruger J.M., et al. Evaluation of modified Wright-staining of urine sediment as a method for accurate detection of bacteriuria in dogs. J Am Vet Med Assoc 224 (2004) 1282-1289
27. Bartges J.W., and Barsanti J.A. Bacterial urinary tract infection in cats. In: Bonagura J.D. (Ed). Kirk's current veterinary therapy XIII small animal practice (2000), WB Saunders Co., Philadelphia 880-882
28. Lees G.E. Epidemiology of naturally occurring bacterial urinary tract infections. Vet Clin North Am Small Anim Pract 14 (1984) 471-479
29. Barsanti J.A., Finco D.R., Shotts E.B., et al. Feline urologic syndrome: further investigations into etiology. J Am Anim Hosp Assoc 18 (1982) 391-395
30. Schechter R.D. The significance of bacteria in feline cystitis and urolithiasis. J Am Vet Med Assoc 156 (1970) 1567-1573
31. Fabricant C.G. Herpesvirus-induced urolithiasis in specific-pathogen-free male cats. Am J Vet Res 38 (1977) 1837-1842
32. Fabricant C.G. The feline urological syndrome induced by infection with a cell-associated herpesvirus. Vet Clin North Am 14 (1984) 493-502
33. Kruger J.M., and Osborne C.A. The role of viruses in feline lower urinary tract disease. J Vet Intern Med 4 (1990) 71-78
34. Fabricant C.G., Gillespie J.H., and Krook L. Intracellular and extracellular mineral crystal formation induced by viral infection of cell cultures. Infect Immun 3 (1971) 416-419
35. Fabricant C.G., King J.M., Gaskin J.M., et al. Isolation of a virus from a female cat with urolithiasis. J Am Vet Med Assoc 158 (1971) 200-201
36. Gaskell R.M., Gaskell C.J., Page W., et al. Studies on a possible etiology for the feline urological syndrome. Vet Rec 105 (1979) 243-247
37. Martens J.G., McConnell S., and Swanson C.L. The role of infectious agents in naturally occurring feline urologic syndrome. Vet Clin North Am Small Anim Pract 14 (1984) 503-511
38. Shroyer E.L., and Shalaby M.R. Isolation of feline syncytia-forming virus from oropharyngeal swab samples and buffy coat cells. Am J Vet Res 39 (1978) 555-560
39. Kruger J.M., Osborne C.A., Venta P.J., et al. Viral infections of the feline urinary tract. Vet Clin North Am Small Anim Pract 26 (1996) 281-296
40. Sutcliffe S., Rohrmann S., Giovannucci E., et al. Viral infections and lower urinary tract symptoms in the third national health and nutrition examination survey. J Urol 178 (2007) 2181-2185
41. Rich L.J., and Fabricant C.G. Urethral obstruction in male cats: transmission studies. Can J Comp Med 33 (1969) 164-165
42. Rich L.J., Fabricant C.G., and Gillespie J.H. Virus induced urolithiasis in male cats. Cornell Vet 61 (1971) 542-553
43. Scansen B.A., Kruger J.M., Wise A.G., et al. In vitro comparison of RNA preparations methods for detection of feline calicivirus in urine in RT-PCR. Am J Vet Res 66 (2005) 915-920
44. Scansen B.A., Wise A.G., Kruger J.M., et al. Evaluation of a p30 gene-based real-time reverse transcriptase PCR assay for detection of feline calicivirus. J Vet Intern Med 18 (2004) 135-138
45. Gaskin J.M., and Gillespie J.H. Detection of feline syncytia-forming virus carrier state with a micro-immunodiffusion test. Am J Vet Res 34 (1973) 245-247
46. German A.C., Harbour D.A., Helps C.R., et al. Is feline foamy virus really a pathogenic?. Vet Immunol Immunopathol 123 (2008) 114-118
47. Kasza L., Hayward A.H.S., and Betts A.O. Isolation of a virus from a cat sarcoma in an established canine melanoma cell line. Res Vet Sci 10 (1969) 216-218
48. Pedersen N.C., Pool R.R., and O'Brian T. Feline chronic progressive polyarthritis. Am J Vet Res 41 (1980) 522-535
49. Fabricant C.G., and Gillespie J.H. Identification and characterization of a second feline herpesvirus. Infect Immun 9 (1974) 460-466
50. Kruger J.M., Osborne C.A., Goyal, et al. Herpesvirus induced urinary tract infection in SPF cats given methylprednisolone. Am J Vet Res 51 (1990) 878-885
51. Kruger J.M., Venta P.J., Swenson C.L., et al. Prevalence of bovine herpesvirus 4 (BHV-4) infection in cats in central Michigan. J Vet Intern Med 14 (2000) 593-597
52. Hansen J.S. Urachal remnant in the cat: occurrence and relationship to the feline urologic syndrome. Vet Med Small Anim Clin 67 (1977) 1090-1095
53. Wilson G.P., Dill L.S., and Goodman R.Z. The relationship of urachal defects in the feline urinary bladder to feline urological syndrome. Proceedings of the 7th Kal Kan symposium (1983), Kal Kan Foods Inc., Vernon (CA) 125-129
54. Noden D.M., and deLahunta A. The urinary system. The embryology of domestic animals (1985), Williams & Wilkins, Baltimore (MD) 312-321
55. Osborne C.A., Johnston G.R., Kruger J.M., et al. Etiopathogenesis and biological behavior of feline vesicourachal diverticula. Vet Clin North Am Small Anim Prac 17 (1987) 697-733
56. Osborne C.A., Kroll R.A., Lulich J.P., et al. Medical management of vesicourachal diverticula in 15 cats with lower urinary tract disease. J Small Anim Pract 30 (1989) 608-612
57. Crawford M.A. The urinary system. In: Hoskins J.D. (Ed). Veterinary pediatrics: dogs and cats from birth to six months (1990), WB Saunders Co, Philadelphia 271-292
58. Fingland R.B. Surgery of the urinary bladder. In: Birchard S.J., and Sherding R.G. (Eds). Saunder's manual of small animal practice (1994), WB Saunders Co, Philadelphia 837-838
59. Osborne C.A., Lulich J.P., Thumchai R., et al. Feline urolithiasis. Etiology and pathophysiology. Vet Clin North Am 26 (1996) 217-232
60. Finco D.R., Barsanti J.A., and Crowell W.A. Characterization of magnesium-induced urinary disease in the cat and comparison with feline urologic syndrome. Am J Vet Res 46 (1985) 391-400
61. Osborne CA, Abdullahi SU, Polzin DJ, et al. Current status of medical dissolution of canine and feline uroliths. In: Proceedings of the 1983 Kal Kan symposium for the treatment of small animal diseases; 1983. p. 53.
62. Osborne C.A., Lulich J.P., Kruger J.M., et al. Medical dissolution of feline struvite urocystoliths. J Am Vet Med Assoc 196 (1990) 1053-1063
63. Buffington C.A., Rogers Q.R., Morris J.G., et al. Feline struvite urolithiasis: magnesium effect depends on urinary pH. Feline Pract 15 (1985) 29-33
64. Jackson J.R., Kealy R.D., Lawler D.F., et al. Long-term safety of urine acidifying diets for cats. Vet Clin Nutr 2 (1995) 100-107
65. Lekcharoensuk C., Osborne C.A., and Lulich J.P. Evaluation of trends in frequency of urethrostomy for treatment of urethral obstruction in cats. J Am Vet Med Assoc 221 (2002) 502-505
66. Hurst R.E., Moldwin R.M., and Mulholland G.S. Bladder defense molecules, urothelial differentiation, urinary biomarkers, and interstitial cystitis. Urology 69 Suppl 4A (2007) 17-23
67. Parsons C.L. The role of the urinary epithelium in the pathogenesis if interstitial cystitis/prostatitis/urethritis. Urology 69 Suppl 4A (2007) 9-16
68. Buffington C.A.T., Blaisdell J.L., Binns Jr. S.P., et al. Decreased urine glycosaminoglycan excretion in cats with interstitial cystitis. J Urol 155 (1996) 1801-1804
69. Gao X., Buffington C.A.T., and Au J.L.S. Effect of interstitial cystitis on drug absorption from urinary bladder. J Pharmacol Exp Ther 271 (1994) 818-823
70. Lavelle J.P., Meyers S.A., Giovani Ruiz W., et al. Urothelial pathophysiological changes in feline interstitial cystitis; a human model. Am J Physiol Renal Physiol 278 (2000) F540-F553
71. Apodaca G. The urothelium; not just a passive barrier. Traffic 5 (2004) 117-128
72. Lewis S.A. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol Renal Physiol 278 (2000) F867-F874
73. Birder L.A. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am J Physiol Renal Physiol 289 (2005) F489-F495
74. Lavelle J., Meyers S., Ramage R., et al. Bladder permeability barrier: recovery from selective injury if the surface epithelial cells. Am J Physiol Renal Physiol 283 (2002) F242-F253
75. Buffington C.A., and Chew D.J. Presence of mast cells in submucosa and detrusor of cats with idiopathic lower urinary tract disease. J Vet Intern Med 7 (1993) 126
76. Buffington C.A.T., Chew D.J., and Woodworth B.E. Animal model of human disease: feline interstitial cystitis. Comp Pathol Bull 29 (1997) 3-4
77. Clasper M. A case of interstitial cystitis and Hunner's ulcer in a domestic short hair cat. N Z Vet J 38 (1990) 158-160
78. Reche- Jr. A., and Hagiwara M.K. Histopathology and morphometry of urinary bladder of cats with idiopathic lower urinary tract disease. Ciência Rural 31 (2001) 1045-1049
79. Specht A.J., Kruger J.M., Fitzgerald S.D., et al. Light microscopic features of feline idiopathic cystitis. J Vet Intern Med 17 (2003) 436
80. Specht A.J., Kruger J.M., Fitzgerald S.D., et al. Histochemical and immunohistochemical features of chronic feline idiopathic cystitis. J Vet Intern Med 18 (2004) 416
81. Parsons C.L., Boychuk D., Jones S., et al. Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143 (1990) 139-142
82. Buffington C.A.T., Chew D.J., and DiBartola S.P. Interstitial cystitis in cats. Vet Clin North Am Small Anim Pract 26 (1996) 317-326
83. Press S.M., Moldwin R., Kushner L., et al. Decreased expression of GP-51 glycosaminoglycan in acts afflicted with feline interstitial cystitis. J Urol 153 Suppl 4 (1995) 288A
84. Westropp J.L., Kass P.H., and Buffington C.A.T. Evaluation of the effects of stress in cats with idiopathic cystitis. Am J Vet Res 67 (2006) 731-736
85. Hurst R.E., Parsons C.L., Roy J.B., et al. Urinary glycosaminoglycan as a laboratory marker in the diagnosis of interstitial cystitis. J Urol 149 (1993) 31-35
86. Parsons C.L., Lilly J.D., and Stein P. Epithelial dysfunction in non-bacterial cystitis (interstitial cystitis). J Urol 145 (1991) 732-735
87. Chelsky M.J., Rosen S.I., Knight L.C., et al. Bladder permeability in interstitial cystitis is similar to that of normal volunteers: direct measurement by transvesical absorption of 99mtechnetium-diethylenetriaminepentaacetic acid. J Urol 151 (1994) 346-349
88. Dixon J.S., Holm-Bentzen M., Gilpin C.J., et al. Electron microscopic investigation of the bladder urothelium and glycocalyx in patients with interstitial cystitis. J Urol 135 (1986) 621-625
89. Erickson D.R., Ordille S., Martin A., et al. Urinary chondroitin sulfates, heparan sulfate and total sulfated glycosaminoglycans in interstitial cystitis. J Urol 157 (1997) 61-64
90. Nickel J.C., Emerson C., and Cornish J. The bladder mucus (glycosaminoglycan) layer in interstitial cystitis. J Urol 149 (1993) 716-718 1993
91. Nikkila M.T. Urinary glycosaminoglycan excretion in normal and stone-forming subjects: significant disturbance in recurrent stone formers. Urol Int 44 (1989) 147-159 1989
92. Ryall R.L., and Marshall V.R. The value of the 24-hour urine analysis in the assessment of stone-formers attending a general hospital outpatient clinic. Br J Urol 55 (1983) 1-5
93. Bade J.J., Laseur M., Nieuwenburg A., et al. A placebo-controlled study of intravesicular pentosanpolysulfate for the treatment of interstitial cystitis. Br J Urol 79 (1997) 168-171
94. Davis E.L., El Khoudary S.R., Talbott E.O., et al. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis; a randomized double-blind clinical trial. J Urol 179 (2008) 177-185
95. Molholland S.G., Hanno P., Parsons C.L., et al. Pentosan polysulfate sodium for therapy of interstitial cystitis; a double-blind placebo-controlled clinical study. Urology 35 (1990) 552-558
96. Jezernik K., Romih R., Mannherz H.G., et al. Immunohistochemical detection of apoptosis, proliferation and inducible nitric oxide synthetase in rat urothelium damaged by cyclophosphamide treatment. Cell Biol Int 27 (2003) 863-869
97. Veranič P., and Jezernik K. The response of junctional complexes to induced desquamation in mouse bladder urothelium. Biol Cell 92 (2000) 105-113
98. Veranič P., and Jezernik K. Succession of events in desquamation of superficial urothelial cells as a response to stress induced by prolonged illumination. Tissue Cell 33 (2001) 280-285
99. Johansson S.L., and Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol 143 (1990) 1118-1124
100. Rosamilia A., Igawa Y., and Higashi S. Pathology of interstitial cystitis. Int J Urol 10 (2003) S11-S15
101. Slobobov G., Feloney M., Gran C., et al. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 171 (2004) 1554-1558
102. Keay S., and Warren J.W. A hypothesis for the etiology of interstitial cystitis based on inhibition of bladder epithelial repair. Med Hypotheses 51 (1998) 79-83
103. Hauser P.J., Dozmorov M.G., Bane B.L., et al. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with intersitial cystitis. J urol 179 (2008) 764-769
104. Laguna P., Smedts F., Nordling J., et al. Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis. Am J Clin Pathol 125 (2006) 105-110
105. Moskowitz M.O., Byrne D.S., Callahan H.J., et al. Decreased expression of a glycoprotein component of bladder surface mucin (GP1) in interstitial cystitis. J Urol 151 (1994) 343-345
106. Keay S., Zhang C.-O., Trifillis A.L., et al. Decreased 3H-thymidine incorporation by human bladder epithelial cells following exposure to urine from interstitial cystitis patients. J Urol 156 (1996) 2073-2078
107. Keay S., Seiller-Moiseiwitsch F., Zhang C.-O., et al. Changes in human bladder epithelial cell gene expression associated with interstitial cystitis or antiproliferative factor treatment. Physiol Genomics 14 (2003) 107-115
108. Keay S., Zhang C.-O., Shoenfelt J.L., et al. Decreased in vitro proliferation of bladder epithelial cells from patients with interstitial cystitis. Urology 61 (2003) 1278-1284
109. Zhang C.-O., Wang J.-Y., Koch K.R., et al. Regulation of tight junction proteins and bladder epithelial paracellular permeability by an antiproliferative factor from patients with interstitial cystitis. J Urol 174 (2005) 2382-2387
110. Jasmin L., and Janni G. Experimental neurogenic cystitis. Adv Exp Med Biol 539 (2003) 319-331
111. Sant G.R., Kempuraj K., Marchand J.E., et al. The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69 Suppl 4A (2007) 34-40
112. Church M.K., Lowman M.A., Rees P.H., et al. Mast cells, neuropeptides and inflammation. Agents Actions 27 (1989) 8-16
113. Foreman J.C. Peptides and neurogenic inflammation. Br Med Bull 43 (1987) 386-400
114. McDonald D.M. Neurogenic inflammation in the respiratory tracts: actions of sensory nerve mediators on blood vessels and epithelium of the airway mucosa. Am Rev Respir Dis 136 (1987) 565-572
115. Payan D.G., Levine J.D., and Goetzl E.J. Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 132 (1984) 1601-1604
116. Galli S.J. New concepts about the mast cell. N Engl J Med 328 (1993) 257-265
117. Elbadawi A.E., and Light J.K. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int 56 (1996) 137-162
118. LeTourneau R., Pang X., Sant G.R., et al. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br J Urol 77 (1996) 41-54
119. Pang X., Boucher W., Triadafilopoulos G., et al. Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology 47 (1995) 436-438
120. Theoharides T.C., Kempuraj D., and Sant G.R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology 57 Suppl 6A (2001) 47-55
121. Theoharides T.C., Sant G.R., El-Mansoury M., et al. Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J Urol 153 (1995) 629-636
122. 3H] substance P in urinary bladders of cats with interstitial cystitis. J Urol 160 (1996) 605-611
123. Buffington C.A.T., and Chew D.J. Does interstitial cystitis occur in cats?. In: Kirk R.W., and Bonagura J.D. (Eds). Current veterinary therapy XII (1995), WB Saunders, Philadelphia 1009-1011
124. Hofmeister M.A., Fang H., Ratliff T.L., et al. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histologic diagnosis via quantitative image analysis and morphometry (QIAM). Urology 49 Suppl 5A (1997) 41-47
125. Sant G.R., and Theoharides T.C. The role of mast cells in interstitial cystitis. Urol Clin North Am 21 (1994) 1-53
126. Lagunoff D., Martin T.W., and Read G. Agents that release histamine from mast cells. Ann Res Pharmacol Toxicol 23 (1993) 331-351
127. Spanos C., Pang X., Ligris K., et al. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 157 (1997) 669-672
128. El-Mansoury M., Boucher W., Sant G.R., et al. Increased urine histamine and methylhistamine in interstitial cystitis. J Urol 152 (1994) 350-353
129. Holm-Bentzen M., Sondergaard I., and Haid T. Urinary excretion of a metabolite of histamine (1,4-methyl-imidazole-acetic acid) in painful bladder disease. Br J Urol 59 (1987) 230-233
130. Christmas T.J., and Rode J. Characteristics of mast cells in normal bladder, bacterial cystitis and interstitial cystitis. Br J Urol 68 (1991) 473-478
131. Buffington CAT. Interstitial cystitis in cats: environmental enrichment and nutrition. In: Proceedings of Hills symposium on lower urinary tract disease. Sunny Isles Beach: 2007. p. 42-4.
132. Buffington C.A.T., Westropp J.L., Chew D.J., et al. Risk factors associate with clinical signs of lower urinary tract disease in indoor-housed cats. J Am Vet Med Assoc 228 (2006) 722-725
133. Buffington C.A.T. External and internal influences on disease risk in cats. J Am Vet Med Assoc 220 (2002) 994-1002
134. Cameron M.E., Casey R.A., Bradshaw J.W.S., et al. A study of environmental and behavioural factors that may be associated with feline idiopathic cystitis. J Small Anim Pract 45 (2004) 144-147
135. Caston H.T. Stress and the feline urological syndrome. Feline Pract 4 (1973) 14-22
136. Jones B.R., Sanson R.L., and Morris R.S. Elucidating the risk factors of feline urologic syndrome. N Z Vet J 45 (1997) 100-108
137. Sternberg E.M., Chrousos G.P., Wilder R.L., et al. The stress response and the regulation of inflammatory disease. Ann Intern Med 117 (1992) 854-866
138. Rothrock N.E., Lutendorf S.K., Kreder K.J., et al. Stress and symptoms in patients with interstitial cystitis. Urology 57 (2001) 422-427
139. Buffington C.A.T., and Pacak K. Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol 165 (2001) 2051-2054
140. Reche- Jr. A., and Buffington C.A.T. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol 159 (1998) 1045-1048
141. Westropp J.L., Welk K.A., and Buffington C.A.T. Small adrenal glands in cats with feline interstitial cystitis. J Urol 170 (2003) 2494-2497
142. Bremner J.D., Krystal J.H., Southwick S.M., et al. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 23 (1996) 28-38
143. 2-adrenoceptors in cats with idiopathic cystitis. Am J Vet Res 68 (2007) 203-207
144. Buffington C.A. Comorbidity if interstitial cystitis with other unexplained clinical conditions. J Urol 172 (2004) 1242-1248
145. Kvetnansky R., Pacak K., Fukuhara K., et al. Sympathoadrenal system in stress: interaction with hypothalamic-pituitary-adrenocortical system. Ann N Y Acad Sci 771 (1995) 131-158
146. Fukuhara K., Kvetnansky R., Cizza G., et al. Interrelations between sympathoadrenal system and hypothalamo-pituitary-adrencortical/thyroid systems in rats exposed to cold stress. J Neuroendocrinol 8 (1996) 533-541
147. Kvetnansky R., Fukuhara K., Pacak K., et al. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology 133 (1993) 1411-1419
148. Makino S., Smith M.A., and Gold P.W. Regulatory role of glucocorticoids and glucocorticoid receptor mRNA levels on tyrosine gene expression in the locus coeruleus during repeated immobilization stress. Brain Res 943 (2002) 216-223
149. Barrington F.J.F. The effect of lesions of the hind- and mid-brain on micturition in the cat. Q J Exp Physiol 15 (1925) 81-102
150. Blok B.F., and Holstege G. The central nervous system control of micturition in cats and humans. Behav Brain Res 92 (1998) 119-125
151. Valentino R.J., Miselis R.R., and Pavcovich L.A. Pontine regulation of pelvic viscera: pharmacologic target for pelvic visceral dysfunctions. Trends Pharmacol Sci 20 (1999) 253-260
152. Valentino R.J., Page M.E., Luppi P.-H., et al. Evidence for widespred afferents to Barrington's nucleus, a brainstem region rich in corticotropin-releasing hormone neurons. Neuroscience 62 (1994) 125-143
153. Lechner S.M., and Valentino R.J. Glucocorticoid receptor-immunoreactivity in corticotropin-releasing factor afferents to the locus coeruleus. Brain Res 816 (1999) 17-28
154. Valentino R.J., Chen S., Zhu Y., et al. Evidence for divergent projections to the brain noradrenergic system and the spinal parasympathetic system from Barrington's nucleus. Brain Res 732 (1996) 1-15
155. Ercan F., San T., and Cavdar S. The effects of cold-restraint stress on urinary bladder wall compared with interstitial cystitis morphology. Urol Res 27 (1999) 454-461
156. Dalal E., Medalia O., Harari O., et al. Moderate stress protects female mice against bacterial infection of the bladder by eliciting uroepithelial shedding. Infect Immun 62 (1994) 5505-5510
157. Buffington C.A.T., Westropp J.L., Chew D.J., et al. Clinical evaluation of multimodal environmental modification (MEMO) in the management of cats with idiopathic cystitis. J Feline Med Surg 8 (2006) 261-268
158. Westropp J.L., and Buffington C.A.T. Feline idiopathic cystitis: current understanding of pathophysiology and management. Vet Clin North Am Small Anim Pract 34 (2004) 1043-1055
159. Kruger J.M., Pfent C.P., Clark A.K., et al. Feline calicivirus-induce urinary tract disease in specific-pathogen-free cats. J Vet Intern Med 21 (2007) 684
160. Larson J., Kruger J.M., Wise A.G., et al. Epidemiology of feline calicivirus urinary tract infection in cats with idiopathic cystitis. J Vet Intern Med 21 (2007) 684
161. Rice C.C., Kruger J.M., Venta P.J., et al. Genetic characterization of 2 novel feline caliciviruses isolated from cats with idiopathic lower urinary tract disease. J Vet Intern Med 16 (2002) 293-302
162. Koch R. Ueber bakteriologische Forschung. "Verh. X Int. Med. Congr, Berlin, 1890" (1892), August Hirschwald, Berlin 35
163. Evans A.S. Causation and disease: the Henle-Koch postulates revisited. Yale J Biol Med 49 (1976) 175-195
164. Lichtenburg F. Infectious disease. In: Cotran R.S., Kumar V., and Robbins S.L. (Eds). Pathologic basis of disease. 4th edition (1989), WB Saunders, Philadelphia 307-315
165. Sosnovtsev S.V., Prikhod'ko E.A., Belliot G., et al. Feline calicivirus replication induces apoptosis in cultured cells. Virus Res 94 (2003) 1-10
166. Willcocks M.M., Carter M.J., and Roberts L.O. Cleavage of eukaryotic initiation factor elF4G and inhibition of host-cell protein synthesis during feline calicivirus infection. J Gen Virol 85 (2004) 1125-1130
167. Makino A., Shimojima M., Miyazawa T., et al. Junctional adhesion molecule 1 is a functional receptor for feline calicivirus. J Virol 80 (2006) 4482-4490
168. Stuart A.D., and Brown T.D.K. α2,6-Linked sialic acid acts as a receptor for feline calicivirus. J Gen Virol 88 (2007) 177-186
169. Ebnet K., Suzuki A., Ohno S., et al. Junctional adhesion molecules (JAMs): more molecules with dual functions?. J Cell Sci 117 (2004) 19-29
170. Barton E.S., Forrest J.C., Connolly J.L., et al. Junction adhesion molecule is a receptor for reovirus. Cell 104 (2001) 441-451
171. Osborne C.A., Kruger J.M., Lulich J.P., et al. Feline matrix-crystalline plugs: a unifying hypothesis of causes. J Small Anim Pract 33 (1992) 172-177